Abdominal aortic aneurysm (AAA) is an enlargement of the aorta greater than 50% in
diameter. Although up to 80% of cases result in mortality if the aneurysm ruptures, patients …

Abdominal aortic aneurysm (AAA) is a severe cardiovascular disease with a high mortality
rate. Several screening and diagnostic methods have been developed for AAA early …

The rupture of an abdominal aortic aneurysm (AAA) causes about 200,000 deaths
worldwide each year. However, there are currently no effective drug therapies to prevent …

Emerging evidence reveals that single nucleotide polymorphism (SNP) within miRNAs can
affect the risk of cardiovascular diseases. However, the role of miRNA SNPs in abdominal …

Abdominal aortic aneurysm (AAA) is a deadly, permanent ballooning of the aortic artery.
Pharmacological and genetic studies have pointed to multiple proteins, including …

Background: Several miRNAs have been implicated in the clinical outcomes of
cardiovascular disorders, but the role of miR-1-3p in abdominal aortic aneurysm (AAA) …

Abdominal aortic aneurysm (AAA) is a degenerative vascular disease impacting aging
populations with a high mortality upon rupture. There are no effective medical therapies to …

Most patients with abdominal aortic aneurysm (AAA) are asymptomatic, being diagnosed
during an imaging evaluation for other symptoms. AAA rupture is an emergency, being one …

Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine
2058. 65 pp. Uppsala: Acta Universitatis Upsaliensis. ISBN 978-91-513-2154-7. Abdominal …

The inability of adult vascular smooth muscle cells (SMCs) to facilitate elastic matrix
regeneration and repair renders it extremely difficult to reverse the pathophysiology of …